Primary PERITONEUM
1 clinical trials · Condition
| Record | Firm | Date |
|---|---|---|
| Intravenous and Intraperitoneal Paclitaxel, Intraperitoneal Cisplatin, and Intravenous Bevacizumab for the Initial Treatment of Optimal Stage II or III Ovarian, Primary Peritoneal, and Fallopian Tube Cancer (NCT00588237) | Memorial Sloan Kettering Cancer Center | 2006-08-01 |
Track Primary PERITONEUM automatically
Every clearance here is in the API, with alerts when new ones post.